Docetere 120 mg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Docetere 120 mg Injection IP contains docetaxel, a taxane cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of breast cancer, prostate cancer, cancers of the head and neck, and non-small cell lung cancer. It is described as interfering with the microtubule structures responsible for the division and multiplication of cancer cells, slowing their growth and eventually killing them. It is administered by a qualified doctor only and may be given alone or in combination with other medications.

Active ingredient
Docetaxel (as trihydrate)
Strength
120 mg
Dosage form
Concentrate for solution for infusion
Therapeutic class
Taxane (antimicrotubule antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Breast cancer — described as relieving symptoms such as breast lumps, breast shape or texture change, and bloody nipple discharge
  • Non-small cell lung cancer — described as treating both smokers and non-smokers
  • Prostate cancer — described as relieving symptoms such as difficulty passing urine by decreasing testosterone in men
  • Cancer of the head and neck — including cancer of the mouth, sinuses, throat, or nose
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Administered by a qualified doctor only; it should not be self-administered
  • Taken exactly as the doctor prescribes; benefits can take weeks or months to be visible
  • Tests for blood cells and liver function may be carried out

Described Side Effects

Commonly described side effects include:

  • Breathlessness
  • Constipation
  • Nail disorder
  • Swelling
  • Infection
  • Loss of appetite
  • Muscle pain
  • Weakness
  • Pain

These are described as completely temporary. The doctor should be contacted if they persist for a longer time.

Precautions

  • The doctor should be informed of heart disease, liver or kidney issues, and any other medicines being taken
  • Avoided during pregnancy or breastfeeding
  • Contraceptives should be used while on this medication to avoid pregnancy
  • Tests for blood cells and liver function may be carried out

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains docetaxel and is used for breast cancer, prostate cancer, head and neck cancers, and non-small cell lung cancer. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as administered by a qualified doctor only, exactly as prescribed, alone or in combination with other medications; it is not to be self-administered.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services